Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sevoflurane Effects on Lung Water in ARDS
NCT04530188Phase 3Unknown
- Sponsor
- Hôpital Bicêtre
- Start
- Nov 2020
- Primary completion
- May 2022
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of sevoflurane in acute respiratory distress syndrome (ARDS), sponsored by Hôpital Bicêtre. Status: unknown.
02
Drugs
sevoflurane
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT04530188.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04530188.